Status:
COMPLETED
Cervical Lidocaine for Intrauterine Device Insertion Pain
Lead Sponsor:
Washington University School of Medicine
Conditions:
Pain
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The aim of this study is to evaluate intracervical lidocaine gel as a means to decrease pain associated with intrauterine device (IUD) insertion. They will be randomized to either placebo (inert water...
Detailed Description
Double blind randomized controlled trial. Primary outcome: Pain reported on Visual Analog Scale (VAS) Intervention: 2% lidocaine gel at the tenaculum site and intracervical prior to intrauterine devi...
Eligibility Criteria
Inclusion
- age 18-45 yrs
- selecting intrauterine device contraception
- able and willing to consent
Exclusion
- non-English speaking
- current intrauterine device use
- expulsion of intrauterine device within 2 weeks
- allergy to lidocaine or water based lubricant
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01411995
Start Date
August 1 2011
End Date
December 1 2011
Last Update
March 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Clinical Research at Washington University
St Louis, Missouri, United States, 63110